REPORT ID 3124

Asia-Pacific Non-opioid Pain Patches Market Report 2017

Publish Date
12-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the Asia-Pacific Non-opioid Pain Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Non-opioid Pain Patches for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Non-opioid Pain Patches market competition by top manufacturers/players, with Non-opioid Pain Patches sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    GlaxoSmithKline
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Hisamitsu Pharmaceutical
    TEH SENG Pharmaceutical
    Teikoku Seiyaku
    IBSA Institut Biochimque SA
    Acorda Therapeutics
    Allergan PLC
    Endo International

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Lidocaine Patch
    Diclofenac Patch
    Methyl Salicylate Patch
    Capsaicin Patch
    Ketoprofen Patch
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Independent Pharmacies & Drug Stores
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Non-opioid Pain Patches Market Report 2017
1 Non-opioid Pain Patches Overview
    1.1 Product Overview and Scope of Non-opioid Pain Patches
    1.2 Classification of Non-opioid Pain Patches by Product Category
        1.2.1 Asia-Pacific Non-opioid Pain Patches Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Non-opioid Pain Patches Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Lidocaine Patch
        1.2.4 Diclofenac Patch
        1.2.5 Methyl Salicylate Patch
        1.2.6 Capsaicin Patch
        1.2.7 Ketoprofen Patch
        1.2.8 Other
    1.3 Asia-Pacific Non-opioid Pain Patches Market by Application/End Users
        1.3.1 Asia-Pacific Non-opioid Pain Patches Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital Pharmacies
        1.3.3 Independent Pharmacies & Drug Stores
        1.3.4 Online Pharmacies
    1.4 Asia-Pacific Non-opioid Pain Patches Market by Region
        1.4.1 Asia-Pacific Non-opioid Pain Patches Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Non-opioid Pain Patches (2012-2022)
        1.5.1 Asia-Pacific Non-opioid Pain Patches Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Non-opioid Pain Patches Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Non-opioid Pain Patches Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Non-opioid Pain Patches Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Non-opioid Pain Patches Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Non-opioid Pain Patches Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Non-opioid Pain Patches (Volume and Value) by Type
        2.2.1 Asia-Pacific Non-opioid Pain Patches Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Non-opioid Pain Patches Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Non-opioid Pain Patches (Volume) by Application
    2.4 Asia-Pacific Non-opioid Pain Patches (Volume and Value) by Region
        2.4.1 Asia-Pacific Non-opioid Pain Patches Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Non-opioid Pain Patches Revenue and Market Share by Region (2012-2017)

3 China Non-opioid Pain Patches (Volume, Value and Sales Price)
    3.1 China Non-opioid Pain Patches Sales and Value (2012-2017)
        3.1.1 China Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        3.1.3 China Non-opioid Pain Patches Sales Price Trend (2012-2017)
    3.2 China Non-opioid Pain Patches Sales Volume and Market Share by Type
    3.3 China Non-opioid Pain Patches Sales Volume and Market Share by Application

4 Japan Non-opioid Pain Patches (Volume, Value and Sales Price)
    4.1 Japan Non-opioid Pain Patches Sales and Value (2012-2017)
        4.1.1 Japan Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Non-opioid Pain Patches Sales Price Trend (2012-2017)
    4.2 Japan Non-opioid Pain Patches Sales Volume and Market Share by Type
    4.3 Japan Non-opioid Pain Patches Sales Volume and Market Share by Application

5 South Korea Non-opioid Pain Patches (Volume, Value and Sales Price)
    5.1 South Korea Non-opioid Pain Patches Sales and Value (2012-2017)
        5.1.1 South Korea Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Non-opioid Pain Patches Sales Price Trend (2012-2017)
    5.2 South Korea Non-opioid Pain Patches Sales Volume and Market Share by Type
    5.3 South Korea Non-opioid Pain Patches Sales Volume and Market Share by Application

6 Taiwan Non-opioid Pain Patches (Volume, Value and Sales Price)
    6.1 Taiwan Non-opioid Pain Patches Sales and Value (2012-2017)
        6.1.1 Taiwan Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Non-opioid Pain Patches Sales Price Trend (2012-2017)
    6.2 Taiwan Non-opioid Pain Patches Sales Volume and Market Share by Type
    6.3 Taiwan Non-opioid Pain Patches Sales Volume and Market Share by Application

7 India Non-opioid Pain Patches (Volume, Value and Sales Price)
    7.1 India Non-opioid Pain Patches Sales and Value (2012-2017)
        7.1.1 India Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        7.1.3 India Non-opioid Pain Patches Sales Price Trend (2012-2017)
    7.2 India Non-opioid Pain Patches Sales Volume and Market Share by Type
    7.3 India Non-opioid Pain Patches Sales Volume and Market Share by Application

8 Southeast Asia Non-opioid Pain Patches (Volume, Value and Sales Price)
    8.1 Southeast Asia Non-opioid Pain Patches Sales and Value (2012-2017)
        8.1.1 Southeast Asia Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Non-opioid Pain Patches Sales Price Trend (2012-2017)
    8.2 Southeast Asia Non-opioid Pain Patches Sales Volume and Market Share by Type
    8.3 Southeast Asia Non-opioid Pain Patches Sales Volume and Market Share by Application

9 Australia Non-opioid Pain Patches (Volume, Value and Sales Price)
    9.1 Australia Non-opioid Pain Patches Sales and Value (2012-2017)
        9.1.1 Australia Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Non-opioid Pain Patches Sales Price Trend (2012-2017)
    9.2 Australia Non-opioid Pain Patches Sales Volume and Market Share by Type
    9.3 Australia Non-opioid Pain Patches Sales Volume and Market Share by Application

10 Asia-Pacific Non-opioid Pain Patches Players/Suppliers Profiles and Sales Data
    10.1 Pfizer
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 GlaxoSmithKline
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Johnson & Johnson
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Novartis AG
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Mylan N.V.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Teva Pharmaceutical Industries
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Hisamitsu Pharmaceutical
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 TEH SENG Pharmaceutical
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Teikoku Seiyaku
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 IBSA Institut Biochimque SA
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Non-opioid Pain Patches Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Acorda Therapeutics
    10.12 Allergan PLC
    10.13 Endo International

11 Non-opioid Pain Patches Manufacturing Cost Analysis
    11.1 Non-opioid Pain Patches Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Non-opioid Pain Patches

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Non-opioid Pain Patches Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Non-opioid Pain Patches Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Non-opioid Pain Patches Market Forecast (2017-2022)
    15.1 Asia-Pacific Non-opioid Pain Patches Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Non-opioid Pain Patches Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Non-opioid Pain Patches Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Non-opioid Pain Patches Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Non-opioid Pain Patches Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Non-opioid Pain Patches Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Non-opioid Pain Patches Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Non-opioid Pain Patches Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Non-opioid Pain Patches Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Non-opioid Pain Patches Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Non-opioid Pain Patches Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Non-opioid Pain Patches Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer